Clinical Trial Detail

NCT ID NCT01537107
Title Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

pancreatic carcinoma

Advanced Solid Tumor

pancreatic acinar cell adenocarcinoma

Therapies

Sirolimus + Vismodegib

Age Groups: adult senior

No variant requirements are available.